146 related articles for article (PubMed ID: 31446206)
1. Effects of cyclosporine and dexamethasone on canine T cell expression of interleukin-2 and interferon-gamma.
Fellman CL; Archer TM; Wills RW; Mackin AJ
Vet Immunol Immunopathol; 2019 Oct; 216():109892. PubMed ID: 31446206
[TBL] [Abstract][Full Text] [Related]
2. Effects of oral cyclosporine on canine T-cell expression of IL-2 and IFN-gamma across a 12-h dosing interval.
Fellman CL; Archer TM; Stokes JV; Wills RW; Lunsford KV; Mackin AJ
J Vet Pharmacol Ther; 2016 Jun; 39(3):237-44. PubMed ID: 26676223
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic monitoring of canine T-cell cytokine responses to oral cyclosporine.
Archer TM; Fellman CL; Stokes JV; Pinchuk LM; Lunsford KV; Pruett SB; Langston VC; Mackin AJ
J Vet Intern Med; 2011; 25(6):1391-7. PubMed ID: 22092633
[TBL] [Abstract][Full Text] [Related]
4. Effects of oral administration of 5 immunosuppressive agents on activated T-cell cytokine expression in healthy dogs.
Archer TM; Mulligan C; Narayanan L; Riggs C; Fellman C; Thomason JM; Wills RW; Boothe DM; Cruz-Espindola C; Harmon R; Mackin AJ
J Vet Intern Med; 2020 May; 34(3):1206-1213. PubMed ID: 32052895
[TBL] [Abstract][Full Text] [Related]
5. In vivo effects of aspirin and cyclosporine on regulatory T cells and T-cell cytokine production in healthy dogs.
Archer TM; Stokes JV; Kummari E; Fellman C; Thomason J; Haraschak J; Wills R; Pinchuk L; Mackin A
Vet Immunol Immunopathol; 2018 Mar; 197():63-68. PubMed ID: 29475508
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine A affects the in vitro expression of T cell activation-related molecules and cytokines in dogs.
Fellman CL; Stokes JV; Archer TM; Pinchuk LM; Lunsford KV; Mackin AJ
Vet Immunol Immunopathol; 2011 Apr; 140(3-4):175-80. PubMed ID: 21227512
[TBL] [Abstract][Full Text] [Related]
7. Effects of pentoxifylline on whole blood IL-2 and IFN-gamma gene expression in normal dogs.
Kummari E; Gibbs A; Riggs C; Fellman C; Stokes J; Thomason J; Wills R; Mackin A; Archer T
Vet Med Sci; 2020 Feb; 6(1):19-24. PubMed ID: 31621209
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation by thalidomide and dexamethasone of cytokine expression in human peripheral blood mononuclear cells.
Rowland TL; McHugh SM; Deighton J; Dearman RJ; Ewan PW; Kimber I
Immunopharmacology; 1998 Jul; 40(1):11-20. PubMed ID: 9776474
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine A inhibits the mRNA expressions of IL-2, IL-4 and IFN-gamma, but not TNF-alpha, in canine mononuclear cells.
Kobayashi T; Momoi Y; Iwasaki T
J Vet Med Sci; 2007 Sep; 69(9):887-92. PubMed ID: 17917372
[TBL] [Abstract][Full Text] [Related]
10. Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients.
Rostaing L; Puyoo O; Tkaczuk J; Peres C; Rouzaud A; Cisterne JM; de Preval C; Ohayon E; Durand D; Abbal M
Clin Transplant; 1999 Oct; 13(5):400-9. PubMed ID: 10515221
[TBL] [Abstract][Full Text] [Related]
11. The novel calcineurin inhibitor ISA247: a more potent immunosuppressant than cyclosporine in vitro.
Bîrsan T; Dambrin C; Freitag DG; Yatscoff RW; Morris RE
Transpl Int; 2005 May; 17(12):767-71. PubMed ID: 15827754
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory in vitro effects of oclacitinib on canine T-cell proliferation and cytokine production.
Banovic F; Tarigo J; Gordon H; Barber JP; Gogal RM
Vet Dermatol; 2019 Feb; 30(1):17-e6. PubMed ID: 30417482
[TBL] [Abstract][Full Text] [Related]
13. Alterations in activated T-cell cytokine expression in healthy dogs over the initial 7 days of twice daily dosing with oral cyclosporine.
Riggs C; Narayanan L; Mulligan C; Wills R; Mackin A; Fellman C; Thomason J; Archer T
J Vet Pharmacol Ther; 2019 Jul; 42(4):385-391. PubMed ID: 30933369
[TBL] [Abstract][Full Text] [Related]
14. Additive immunosuppressive effects of 1,25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responses.
Jirapongsananuruk O; Melamed I; Leung DY
J Allergy Clin Immunol; 2000 Nov; 106(5):981-5. PubMed ID: 11080724
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic assessment of
Grobman M; Bishop KA; Rindt H; Nafe LA; Reinero CR
Can J Vet Res; 2019 Oct; 83(4):279-284. PubMed ID: 31571728
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of cytokine expression after allergen exposure of sensitized rats by cyclosporin A and corticosteroids: relationship to bronchial hyperresponsiveness.
Huang TJ; Newton R; Haddad EB; Chung KF
J Allergy Clin Immunol; 1999 Sep; 104(3 Pt 1):644-52. PubMed ID: 10482841
[TBL] [Abstract][Full Text] [Related]
17. In-vitro immunosuppression of canine T-lymphocyte-specific proliferation with dexamethasone, cyclosporine, and the active metabolites of azathioprine and leflunomide in a flow-cytometric assay.
Nafe LA; Dodam JR; Reinero CR
Can J Vet Res; 2014 Jul; 78(3):168-75. PubMed ID: 24982547
[TBL] [Abstract][Full Text] [Related]
18. Antithrombin III inhibits lymphocyte proliferation, immunoglobulin production and mRNA expression of lymphocyte growth factors (IL-2, gamma-IFN and IL-4) in vitro.
Zuo XJ; Nicolaidou E; Okada Y; Toyoda M; Jordan SC
Transpl Immunol; 2001 Oct; 9(1):1-6. PubMed ID: 11680566
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes.
Franchimont D; Galon J; Gadina M; Visconti R; Zhou Y; Aringer M; Frucht DM; Chrousos GP; O'Shea JJ
J Immunol; 2000 Feb; 164(4):1768-74. PubMed ID: 10657623
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric detection of intracellular IL-12 release: in vitro effect of widely used immunosuppressants.
Tsiavou A; Degiannis D; Hatziagelaki E; Koniavitou K; Raptis S
Int Immunopharmacol; 2002 Nov; 2(12):1713-20. PubMed ID: 12469945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
